Work

Kinase Domain Mutants of Bcr-Abl Exhibit Altered Transformation Potency, Kinase Activity, and Substrate Utilization, Irrespective of Sensitivity to Imatinib.

Year: 2006

Type: article

Source: Blood

DOI: 10.1182/blood.v108.11.4796.4796

Authors: M. MacPartlin, T. O’Hare, T. Bumm, V. Goss, K. Lee, A. Corbin, E.A. Stoffregen, C. Smith, K. Johnson, E. Moseson, I. Griswold, L. Wood, R. Polakiewicz, Brian J. Druker, Michael W.N. Deininger

Institutions: Oregon Health & Science University, Howard Hughes Medical Institute, Cell Signaling Technology (United States)

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2568650137

FWCI: 0.36

Cites:

Cited by: 4

Related to: 10